APTO
Aptose Biosciences, Inc.
APTO
APTO
Delisted
APTO was delisted on the 1st of April, 2025.
58 hedge funds and large institutions have $42.6M invested in Aptose Biosciences, Inc. in 2021 Q4 according to their latest regulatory filings, with 11 funds opening new positions, 22 increasing their positions, 14 reducing their positions, and 17 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
less funds holding
Funds holding: →
35% less first-time investments, than exits
New positions opened: 11 | Existing positions closed: 17
50% less capital invested
Capital invested by funds: $85.8M → $42.6M (-$43.3M)
Holders
58
Holding in Top 10
1
Calls
$197K
Puts
$102K
Top Buyers
| 1 | +$917K | |
| 2 | +$875K | |
| 3 | +$652K | |
| 4 |
Two Sigma Investments
New York
|
+$635K |
| 5 |
Millennium Management
New York
|
+$539K |
Top Sellers
| 1 | -$9M | |
| 2 | -$6.54M | |
| 3 | -$5.66M | |
| 4 |
6CM
683 Capital Management
New York
|
-$1.48M |
| 5 |
OM
Opaleye Management
Boston,
Massachusetts
|
-$1.2M |